Alexandria Real Estate Equities, Inc. Hosts Alexandria Summit™ on Medical Research Philanthropy at Alexandria Center™ for

  Alexandria Real Estate Equities, Inc. Hosts Alexandria Summit™ on Medical
Research Philanthropy at Alexandria Center™ for Life Science in New York City

In conjunction with unprecedented gathering of senior thought leaders to
advance medical research philanthropy, Alexandria releases update on its 2012
corporate responsibility achievements

PR Newswire

NEW YORK, Feb. 28, 2013

NEW YORK, Feb. 28, 2013 /PRNewswire/ --Alexandria Real Estate Equities, Inc.
(NYSE: ARE), the largest and leading owner, operator, and developer of
high-quality, sustainable real estate for the broad and diverse life science
industry, will hold the Alexandria Summit – Medical Research Philanthropy
today at the Alexandria Center for Life Science in New York City. The
Alexandria Summit – Medical Research Philanthropy will bring together senior
thought leaders from academic medical research centers,
foundations/non-profits, government, industry, venture capital, patients, and
patient advocacy groups in a unique and highly interactive forum to
collectively explore how to most effectively and strategically leverage the
vital growing influence of medical research philanthropy in drug discovery,
development, and commercialization. Similar to previous Alexandria Summits,
Alexandria believes that by bringing together the unparalleled intellectual
capital of its longstanding and diverse life science network, it will help
advance the translation of novel, breakthrough discoveries that will save
lives, manage disease, and importantly, reduce the economic burden of disease
on society. The life science industry's breakthrough products represent the
real solution to decreasing the negative economic impact of disease to
society. Alexandria's leadership as the founder and organizer of the
Alexandria Summit further demonstrates the Company's longstanding position as
a trusted and collaborative partner to the life science ecosystem.

In recent years, medical research philanthropy has emerged as a leading and
dynamic positive force in drug discovery and development. The breadth and
depth of its impact – from funding and de-risking investments, to scientific
expertise, to patient recruitment and advocacy – uniquely positions medical
research philanthropy as a truly transformative and increasingly critical
player in the drug discovery and development continuum. Today, esteemed guests
at the Alexandria Summit, including Deborah W. Brooks, MBA (Co-Founder and
Executive Vice Chairman of The Michael J. Fox Foundation for Parkinson's
Research), Kathryn E. Giusti, MBA (Founder and Chief Executive Officer of the
Multiple Myeloma Research Foundation), Mark Levin (Partner at Third Rock
Ventures, LLC), Husseini K. Manji, MD, FRCPC (Global Therapeutic Area Head of
Neuroscience at Janssen Research & Development, LLC), Luca Santarelli, MD
(Senior Vice President, Head of Neuroscience and Small Molecule Research at F.
Hoffmann-La Roche Ltd.), Ellen V. Sigal, PhD (Chairperson and Founder of
Friends of Cancer Research), Craig B. Thompson, MD (President and Chief
Executive Officer of Memorial Sloan-Kettering Cancer Center), David Axelrod
(Former Senior Advisor to President Obama), and Susan Axelrod, MBA (Founder
and Chair of Citizens United for Research in Epilepsy), will come together in
a groundbreaking collaborative platform to advance the promise for innovation
offered by medical research philanthropy.

In conjunction with the Alexandria Summit – Medical Research Philanthropy,
Alexandria is pleased to provide a comprehensive update on its meaningful
corporate responsibility achievements in 2012. Each year, the Alexandria team
dedicates time, effort, and resources to the following strategic areas:

  oLife Science: Enabling our client tenants and longstanding network to
    translate promising discoveries into safe and effective therapies and
    technologies that will address the most critical global healthcare
    challenges and ensure that the right drugs reach patients who need them
    most in a timely manner;
  oCorporate Giving: Supporting leading non-profit organizations in the areas
    of scientific research and development, local community support, military
    service support groups, science education, and opportunistic giving;
  oSustainability: Improving the workplace environment and reducing our
    environmental footprint through sustainable, efficient building design and
    operations; and
  oVolunteerism: Serving our cluster communities through employee volunteer
    programs, company-sponsored volunteering activities, and annual charity

2012 was an unparalleled year of corporate giving for Alexandria. Alexandria
made meaningful contributions to a selection of world-class non-profit
organizations including Autism Speaks, Boston Children's Hospital, Citizens
United for Research in Epilepsy, Dana-Farber Cancer Institute, Friends of
Cancer Research, JDRF, Multiple Myeloma Research Foundation, Seattle
Children's Hospital, and The Michael J. Fox Foundation for Parkinson's
Research. Alexandria also made a number of significant donations to military
service support groups including the Central Intelligence Agency Officers
Memorial Foundation, Navy SEAL Foundation, Wounded Explosive Ordnance Disposal
Warrior Foundation, and Wounded Warrior Project, to assist the important,
unmet needs of the men, women, and families who serve our nation. In 2012, 59%
of Alexandria's donations went to scientific research and development, 21% to
local community support, 18% to military service support, 1% to science
education, and 1% to opportunistic events.

"Since Alexandria was founded in 1994, we have always strived to make good
citizenship integral to our mission," said Joel S. Marcus, Chairman, Chief
Executive Officer, and Founder of Alexandria. "By enabling scientific
breakthroughs through the provision of our world-class facilities and
services, and by supporting leading non-profit organizations in our clusters,
protecting the environment and its natural resources, and helping those who
faithfully serve our country, we work every day to make a positive impact in
our communities."

In 2012, Alexandria continued to advance its real estate sustainability
platform. To date, Alexandria has 16 LEED^® (Leadership in Energy and
Environmental Design) certifications encompassing approximately 2.5 million
rentable square feet, with another 24 LEED certifications in process totaling
approximately 4.2 million rentable square feet. Upon completion of these
projects, approximately 47% of Alexandria's operating portfolio will be

Beyond LEED certifications, Alexandria seeks to advance the resource
efficiency and environmental ecosystem of its facilities to produce the most
collaborative, innovative, productive and sustainable work environments for
its client tenants. In 2012, Alexandria engaged third party consultants to
conduct facility energy benchmarking and audits of its sustainability
operations to help enhance its facilities and best practices for laboratory
space management. Other initiatives include the implementation of energy
optimization projects, ecofriendly transportation amenities, onsite healthy
meal choices, fitness centers, and sustainable gardens.

One of Alexandria's newest, most sustainable campuses, ARE Nautilus in San
Diego, recently won the Most Innovative Deal of the Year Award by the San
Diego Business Journal. ARE Nautilus is a highly sustainable facility designed
to achieve LEED Gold Core and Shell certification. Some of ARE Nautilus'
sustainable features include two facilities projected to perform approximately
15% better than the national standard for energy efficiency; high-efficiency
glazing and lighting systems, and a "cool roof" to reduce baseline energy
consumption; significantly reduced water consumption both inside and outside
of the buildings; a drought-tolerant plant palette in combination with a
high-efficiency irrigation system that reduces water consumption outside the
building by more than 50%; and fitness rooms and showering facilities
providing client tenants with a place to refresh after walking or biking to
work. Designed at the forefront of sustainability, collaboration, and
innovation, ARE Nautilus is nearly fully leased to high-quality client tenants
including Novartis AG, Sequenom, Inc., The Scripps Research Institute, and
Verenium Corporation.

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and
self-managed real estate investment trust (REIT), is the largest and leading
investment-grade REIT focused principally on owning, operating, redeveloping,
developing, and acquiring high-quality, sustainable real estate for the broad
and diverse life science industry. Founded in 1994, Alexandria was the first
REIT to identify and pursue a primary focus on the laboratory niche and has
since had the first-mover advantage in every core life science cluster
location including Greater Boston, the San Francisco Bay Area, San Diego, New
York City, Seattle, Suburban Washington, D.C., and Research Triangle Park.
Alexandria's high-credit client tenants span the life science industry,
including renowned academic medical research centers, multinational
pharmaceutical companies, public and private biotechnology entities, U.S.
government research agencies, medical device companies, industrial
biotechnology companies, venture capitalists, and life science product and
service companies. Forty-seven percent of Alexandria's total annualized base
rent is from investment grade tenants. As the recognized real estate partner
of the life science industry, Alexandria has a superior track record in
driving client tenant productivity, collaboration, and innovation through its
CBD locations adjacent to leading academic medical research centers,
best-in-class laboratory/office space, unparalleled life science real estate
expertise and services, and longstanding and expansive network in the life
science community, which we believe result in higher occupancy levels, longer
lease terms, higher rental income, higher returns, and greater long-term asset
value. For more information, please visit

This press release contains forward-looking statements within the meaning of
the federal securities laws. Actual results may differ materially from those
projected in the forward-looking statements. Additional information concerning
factors that could cause actual results to differ materially from those in the
forward-looking statements is contained in our Annual Report on Form 10-K and
our other periodic reports filed with the Securities and Exchange Commission.

SOURCE Alexandria Real Estate Equities, Inc.

Contact: Joel S. Marcus, Chairman, Chief Executive Officer, & Founder,
Alexandria Real Estate Equities, Inc., +1-626-578-9693
Press spacebar to pause and continue. Press esc to stop.